$480.59M
Revenue
$2.31M
Net Income
85.15%
Gross Margin
-1.38%
Op. Margin
$82.56M
Free Cash Flow
| Breakdown | Q4 2026 (Jan 31, 2026) |
Q3 2026 (Oct 31, 2025) |
Q2 2026 (Jul 31, 2025) |
Q1 2026 (Apr 30, 2025) |
Q4 2025 (Jan 31, 2025) |
Q3 2025 (Oct 31, 2024) |
Q2 2025 (Jul 31, 2024) |
|---|---|---|---|---|---|---|---|
| Total Revenue | $127.07M | $120.33M | $117.25M | $115.94M | $109.68M | $106.80M | - |
| Revenue Growth % (YoY) | 15.9% | 12.7% | nan% | nan% | nan% | nan% | - |
| Cost of Revenue | $18.99M | $18.34M | $17.40M | $16.64M | $16.51M | $17.85M | - |
| Gross Profit | $108.08M | $102.00M | $99.86M | $99.30M | $93.17M | $88.95M | - |
| Gross Margin % | 85.1% | 84.8% | 85.2% | 85.6% | 84.9% | 83.3% | - |
| Operating Expenses | $132.62M | $116.59M | $118.76M | $119.22M | $117.29M | $120.64M | - |
| Research & Development | $30.93M | $29.45M | $29.27M | $31.83M | $29.63M | $29.32M | - |
| Operating Income | $-5.56M | $3.74M | $-1.51M | $-3.29M | $-7.61M | $-13.84M | - |
| Operating Margin % | -4.4% | 3.1% | -1.3% | -2.8% | -6.9% | -13.0% | - |
| Interest Expense | $721.00K | $239.00K | $330.00K | $324.00K | $735.00K | $595.00K | - |
| Other Income/Expense | $1.27M | $1.01M | $336.00K | $338.00K | $2.22M | $-144.00K | - |
| Income Before Tax | $-10.32M | $5.12M | $-563.00K | $-3.18M | $-5.38M | $-13.96M | - |
| Income Tax Expense | $-11.62M | $854.00K | $-1.22M | $735.00K | $1.01M | $442.00K | - |
| Net Income | $1.29M | $4.27M | $654.00K | $-3.91M | $-6.39M | $-14.40M | - |
| Net Margin % | 1.0% | 3.5% | 0.6% | -3.4% | -5.8% | -13.5% | - |
| Basic EPS | nan | 0.07 | 0.01 | -0.07 | -0.11 | -0.25 | - |
| Diluted EPS | nan | 0.07 | 0.01 | -0.07 | -0.11 | -0.25 | - |
| Basic Shares Outstanding | 224K | 60.0M | 59.6M | 58.9M | 231K | 57.9M | - |
| Diluted Shares Outstanding | 3K | 61.6M | 61.7M | 58.9M | 231K | 57.9M | - |
| Breakdown | Q4 2026 (Jan 31, 2026) |
Q3 2026 (Oct 31, 2025) |
Q2 2026 (Jul 31, 2025) |
Q1 2026 (Apr 30, 2025) |
Q4 2025 (Jan 31, 2025) |
Q3 2025 (Oct 31, 2024) |
Q2 2025 (Jul 31, 2024) |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $73.83M | $106.37M | $98.27M | $90.87M | $84.22M | $81.74M | - |
| Accounts Receivable | $97.45M | $88.26M | $76.84M | $75.10M | $73.62M | $71.41M | - |
| Other Current Assets | $17.98M | $20.46M | $18.23M | $16.02M | $15.87M | $11.02M | - |
| Total Current Assets | $279.84M | $240.91M | $222.64M | $215.41M | $203.28M | $189.57M | - |
| Goodwill | $170.06M | $75.84M | $75.84M | $75.84M | $75.84M | $75.84M | - |
| Intangible Assets | $79.76M | $25.53M | $26.40M | $27.27M | $28.14M | $29.01M | - |
| Other Non-current Assets | $2.44M | $3.08M | $3.86M | $3.12M | $2.67M | $1.87M | - |
| Total Assets | $663.79M | $423.47M | $408.63M | $400.39M | $388.42M | $375.70M | - |
| Accounts Payable | $11.48M | $6.22M | $6.53M | $3.20M | $5.62M | $15.87M | - |
| Accrued Liabilities | $41.26M | $30.52M | $34.78M | $34.06M | $37.46M | $29.08M | - |
| Deferred Revenue | $49.52M | $29.71M | $26.91M | $31.15M | $32.76M | $22.19M | - |
| Other Current Liabilities | $705.00K | - | - | - | - | $7.13M | - |
| Total Current Liabilities | $183.24M | $98.78M | $105.14M | $110.72M | $114.02M | $109.20M | - |
| Long-term Debt | $2.66M | $3.35M | $4.58M | $6.16M | $8.15M | $10.29M | - |
| Other Non-current Liabilities | $47.00K | $41.00K | $45.00K | $246.00K | $185.00K | $133.00K | - |
| Total Liabilities | $326.58M | $103.14M | $110.64M | $118.21M | $123.61M | $121.11M | - |
| Common Stock | $620.00K | $616.00K | $611.00K | $608.00K | $601.00K | $594.00K | - |
| Retained Earnings | $-799.19M | $-800.49M | $-804.76M | $-805.41M | $-801.50M | $-795.11M | - |
| Total Stockholders Equity | $337.21M | $320.33M | $297.99M | $282.19M | $264.81M | $254.59M | - |
| Total Liabilities & Equity | $663.79M | $423.47M | $408.63M | $400.39M | $388.42M | $375.70M | - |
| Breakdown | Q4 2026 (Jan 31, 2026) |
Q3 2026 (Oct 31, 2025) |
Q2 2026 (Jul 31, 2025) |
Q1 2026 (Apr 30, 2025) |
Q4 2025 (Jan 31, 2025) |
Q3 2025 (Oct 31, 2024) |
Q2 2025 (Jul 31, 2024) |
|---|---|---|---|---|---|---|---|
| Net Income | $1.29M | $4.27M | $-3.26M | $-3.91M | $-6.39M | $-52.14M | - |
| Depreciation & Amortization | $9.69M | $7.48M | $7.41M | $6.88M | $6.82M | $21.06M | - |
| Stock-based Compensation | $18.04M | $15.96M | $16.23M | $17.23M | $17.16M | $16.52M | - |
| Change in Receivables | $8.63M | $11.46M | $3.31M | $1.49M | $2.25M | $6.56M | - |
| Change in Payables | $3.63M | $1.30M | $2.07M | $-1.74M | $-8.43M | $5.20M | - |
| Operating Cash Flow | $33.66M | $15.47M | $29.68M | $14.85M | $16.26M | $5.79M | - |
| Capital Expenditure | $2.56M | $3.27M | $1.77M | $3.50M | $2.79M | $5.92M | - |
| Acquisitions | - | - | - | - | - | - | - |
| Investing Cash Flow | $-142.62M | $-6.67M | $-5.20M | $-7.39M | $-7.06M | $-17.03M | - |
| Financing Cash Flow | $76.50M | $-667.00K | $-2.15M | $-838.00K | $-6.63M | $-4.86M | - |
| Net Change in Cash | $-32.54M | $8.11M | $14.05M | $6.65M | $2.48M | $-58.00K | - |
SEC Filing Format - Data shown as it appears in the Q3 2026 (10-Q) filing
Period ended: Oct 31, 2025
Condensed Consolidated Statements of Operations
| Description | Oct 31, 2025 | Oct 31, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $120.33M | - | $353.52M | - |
| Cost of Revenue | $18.34M | - | $52.37M | - |
| Operating Expenses | $116.59M | - | $354.58M | - |
| Research & Development | $29.45M | - | $90.56M | - |
| Operating Income | $3.74M | - | $-1.05M | - |
| Interest Expense | $239.00K | - | $893.00K | - |
| Other Income/Expense | $1.01M | - | $1.68M | - |
| Income Before Tax | $5.12M | - | $1.38M | - |
| Income Tax Expense | $854.00K | - | $372.00K | - |
| Net Income | $4.27M | $-18.01M | $1.01M | - |
| Basic EPS | 0.07 | - | 0.02 | - |
| Diluted EPS | 0.07 | - | 0.02 | - |
| Basic Shares Outstanding | $60.01M | - | $59.51M | - |
| Diluted Shares Outstanding | $61.56M | - | $61.49M | - |
Condensed Consolidated Balance Sheets
| Description | Oct 31, 2025 | Jan 31, 2025 |
|---|---|---|
| Cash & Cash Equivalents | $106.37M | $84.22M |
| Accounts Receivable | $88.26M | $73.62M |
| Other Current Assets | $20.46M | $15.87M |
| Total Current Assets | $240.91M | $203.28M |
| Goodwill | $75.84M | $75.84M |
| Intangible Assets | $25.53M | $28.14M |
| Other Non-current Assets | $3.08M | $2.67M |
| Total Assets | $423.47M | $388.42M |
| Accounts Payable | $6.22M | $5.62M |
| Accrued Liabilities | $30.52M | $37.46M |
| Deferred Revenue | $29.71M | $32.76M |
| Total Current Liabilities | $98.78M | $114.02M |
| Long-term Debt | $3.35M | $8.15M |
| Other Non-current Liabilities | $41.00K | $185.00K |
| Total Liabilities | $103.14M | $123.61M |
| Common Stock | $616.00K | $601.00K |
| Retained Earnings | $-800.49M | $-801.50M |
| Total Stockholders Equity | $320.33M | $264.81M |
| Total Liabilities & Equity | $423.47M | $388.42M |
Condensed Consolidated Statements of Cash Flows
| Description | Oct 31, 2025 | Oct 31, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $4.27M | $-18.01M | $1.01M | - |
| Depreciation & Amortization | $7.48M | - | $21.77M | - |
| Stock-based Compensation | $15.96M | - | $49.41M | - |
| Change in Receivables | $11.46M | - | $14.77M | - |
| Change in Payables | $1.30M | - | $1.63M | - |
| Operating Cash Flow | $15.47M | - | $45.15M | - |
| Capital Expenditure | $3.27M | - | $8.54M | - |
| Investing Cash Flow | $-6.67M | - | $-19.26M | - |
| Financing Cash Flow | $-667.00K | - | $-3.65M | - |
| Net Change in Cash | $8.11M | - | $22.15M | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.